Texas Home Care Valuation Multiples in 2026
A Texas-focused look at home care valuation multiples in 2026. Learn what buyers are paying, how EBITDA drives value, and what Texas agency owners can do to protect and increase their sale price.
Category: Blog Posts
What the New CMS Rules Mean for Home Health Providers — And How They Impact Your Agency’s Valuation in 2026 & Beyond
Home health and hospice owners are facing major CMS changes—from the new Team Model to MedPAC’s proposed 7% payment cut. These shifts directly influence valuation, buyer appetite, and the timing of your exit. Learn how these rules affect what your agency is worth, what buyers look for now, and how to protect your value before selling.
Closing? Why Healthcare Sellers Are Facing Longer Timelines & How to Stay in Control of Your Exit
Closing is taking longer than ever for healthcare agency sales—often 9–10+ months—but that doesn’t mean sellers are powerless. This guide explains why timelines have stretched, what really slows deals down, and how home health and home care owners can prepare in advance to protect valuation and stay in control of closing.
What the Final CMS Rule Means for Home Health Care & What That Means If You Want to Sell
CMS’s Final Rule for 2026 cuts Medicare home health payments by 1.3% and adds more pressure under PDGM. In this breakdown, Vallexa Advisors explains what the rule really means for home health and home care valuations—and how agency owners can protect their value or plan an exit on their terms.
How to Sell a Home Care Agency: AI Tools + Expert M&A Advice
AI is transforming how home health owners prepare, value, and sell their agencies. Learn how Vallexa Advisors and BuiltForYou.ai use cutting-edge automation, compliance tech, and real-time buyer insights to help you increase your valuation, streamline operations, and sell your home health care business for maximum value.
Sell or Buy a Home Health Care Business: Your 2026 Guide | home care business for sale
Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.
Hospice Valuation amid Fraud Crackdowns, Shutdowns & Policy Shifts: What Owners Need to Know
Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.
How the 2026 Final Rule and HOPE Tool Shape Hospice Valuation
The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agency’s value — and how Vallexa Advisors helps owners navigate the changing market.
Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth
Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.
Comprehensive Guide to Selling Senior Healthcare Businesses: Assisted Living, Hospice, Home Health & More
Unlock the secrets to sell a senior healthcare business effectively, from understanding valuations to maximizing your sale.